Literature DB >> 30617753

Semiparametric inference for a two-stage outcome-dependent sampling design with interval-censored failure time data.

Qingning Zhou1, Jianwen Cai2, Haibo Zhou3.   

Abstract

We propose a two-stage outcome-dependent sampling design and inference procedure for studies that concern interval-censored failure time outcomes. This design enhances the study efficiency by allowing the selection probabilities of the second-stage sample, for which the expensive exposure variable is ascertained, to depend on the first-stage observed interval-censored failure time outcomes. In particular, the second-stage sample is enriched by selectively including subjects who are known or observed to experience the failure at an early or late time. We develop a sieve semiparametric maximum pseudo likelihood procedure that makes use of all available data from the proposed two-stage design. The resulting regression parameter estimator is shown to be consistent and asymptotically normal, and a consistent estimator for its asymptotic variance is derived. Simulation results demonstrate that the proposed design and inference procedure performs well in practical situations and is more efficient than the existing designs and methods. An application to a phase 3 HIV vaccine trial is provided.

Entities:  

Keywords:  Bernstein polynomial; Biased sampling; Missing data; Proportional hazards model; Sieve estimation

Mesh:

Year:  2019        PMID: 30617753      PMCID: PMC6612481          DOI: 10.1007/s10985-019-09461-5

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  15 in total

1.  Weighted likelihood method for grouped survival data in case-cohort studies with application to HIV vaccine trials.

Authors:  Zhiguo Li; Peter Gilbert; Bin Nan
Journal:  Biometrics       Date:  2008-12       Impact factor: 2.571

2.  A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix.

Authors:  J CORNFIELD
Journal:  J Natl Cancer Inst       Date:  1951-06       Impact factor: 13.506

3.  Marginal hazards model for case-cohort studies with multiple disease outcomes.

Authors:  S Kang; J Cai
Journal:  Biometrika       Date:  2009-12       Impact factor: 2.445

Review 4.  Recent progresses in outcome-dependent sampling with failure time data.

Authors:  Jieli Ding; Tsui-Shan Lu; Jianwen Cai; Haibo Zhou
Journal:  Lifetime Data Anal       Date:  2016-01-13       Impact factor: 1.588

5.  Case-cohort studies with interval-censored failure time data.

Authors:  Q Zhou; H Zhou; J Cai
Journal:  Biometrika       Date:  2017-02-03       Impact factor: 2.445

6.  Statistical inference for the additive hazards model under outcome-dependent sampling.

Authors:  Jichang Yu; Yanyan Liu; Dale P Sandler; Haibo Zhou
Journal:  Can J Stat       Date:  2015-09       Impact factor: 0.875

7.  Statistical inference for a two-stage outcome-dependent sampling design with a continuous outcome.

Authors:  Haibo Zhou; Rui Song; Yuanshan Wu; Jing Qin
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

8.  Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

Authors:  Clayton D Harro; Franklyn N Judson; Geoffrey J Gorse; Kenneth H Mayer; Jay R Kostman; Stephen J Brown; Beryl Koblin; Michael Marmor; Bradford N Bartholow; Vladimir Popovic
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

9.  Estimating effect of environmental contaminants on women's subfecundity for the MoBa study data with an outcome-dependent sampling scheme.

Authors:  Jieli Ding; Haibo Zhou; Yanyan Liu; Jianwen Cai; Matthew P Longnecker
Journal:  Biostatistics       Date:  2014-05-07       Impact factor: 5.899

10.  A semiparametric empirical likelihood method for data from an outcome-dependent sampling scheme with a continuous outcome.

Authors:  Haibo Zhou; M A Weaver; J Qin; M P Longnecker; M C Wang
Journal:  Biometrics       Date:  2002-06       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.